Cavallari L, Hicks J, Patel J, Elchynski A, Smith D, Bargal S
Pharmacogenet Genomics. 2024; 35(1):1-11.
PMID: 39485373
PMC: 11664750.
DOI: 10.1097/FPC.0000000000000547.
Ausi Y, Barliana M, Postma M, Suwantika A
J Multidiscip Healthc. 2024; 17:4863-4874.
PMID: 39464786
PMC: 11512769.
DOI: 10.2147/JMDH.S458564.
Tunehag K, Thomas C, Franchi F, Rossi J, Keeley E, Anderson R
J Am Heart Assoc. 2024; 13(12):e033791.
PMID: 38874073
PMC: 11255757.
DOI: 10.1161/JAHA.123.033791.
Yuan D, Park J, Li Z, Thomas R, Hwang D, Fu L
Genes (Basel). 2024; 15(3).
PMID: 38540411
PMC: 10969787.
DOI: 10.3390/genes15030352.
Principi N, Petropulacos K, Esposito S
Pharmaceuticals (Basel). 2023; 16(11).
PMID: 38004461
PMC: 10675377.
DOI: 10.3390/ph16111596.
Medication reconciliation to support pharmacogenomics implementation.
Mosley S, Pevnick J
Ann Transl Med. 2023; 10(23):1258.
PMID: 36618811
PMC: 9816836.
DOI: 10.21037/atm-2022-57.
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing.
Cavallari L, Pratt V
Clin Lab Med. 2022; 42(4):533-546.
PMID: 36368780
PMC: 9896522.
DOI: 10.1016/j.cll.2022.09.009.
Evaluation of Potential Racial Disparities in CYP2C19-Guided P2Y Inhibitor Prescribing After Percutaneous Coronary Intervention.
Cavallari L, Limdi N, Beitelshees A, Lee J, Duarte J, Franchi F
Clin Pharmacol Ther. 2022; 113(3):615-623.
PMID: 36306392
PMC: 9957848.
DOI: 10.1002/cpt.2776.
Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians' attitudes to sociocultural differences between patients across the globe.
Pinzon-Espinosa J, van der Horst M, Zinkstok J, Austin J, Aalfs C, Batalla A
Transl Psychiatry. 2022; 12(1):442.
PMID: 36220808
PMC: 9553897.
DOI: 10.1038/s41398-022-02203-6.
Evaluation of race and ethnicity disparities in outcome studies of genotype-guided antiplatelet therapy.
Nguyen A, Cavallari L, Rossi J, Stouffer G, Lee C
Front Cardiovasc Med. 2022; 9:991646.
PMID: 36082121
PMC: 9445150.
DOI: 10.3389/fcvm.2022.991646.
Characterizing pharmacogenetic programs using the consolidated framework for implementation research: A structured scoping review.
McDermott J, Wright S, Sharma V, Newman W, Payne K, Wilson P
Front Med (Lausanne). 2022; 9:945352.
PMID: 36059837
PMC: 9433561.
DOI: 10.3389/fmed.2022.945352.
Pharmacogenetics of Antiplatelet Therapy.
Castrichini M, Luzum J, Pereira N
Annu Rev Pharmacol Toxicol. 2022; 63:211-229.
PMID: 35914768
PMC: 9868113.
DOI: 10.1146/annurev-pharmtox-051921-092701.
A physiologically based pharmacokinetic model of clopidogrel in populations of European and Japanese ancestry: An evaluation of CYP2C19 activity.
Duong J, Nand R, Patel A, Della Pasqua O, Gross A
Pharmacol Res Perspect. 2022; 10(2):e00946.
PMID: 35307978
PMC: 8934724.
DOI: 10.1002/prp2.946.
Pharmacogenomic prescribing opportunities in percutaneous coronary intervention and bone marrow transplant patients.
Ratner L, Zhu J, Gower M, Patel T, Miller J, Cipriani A
Pharmacogenomics. 2022; 23(3):183-194.
PMID: 35083934
PMC: 8914581.
DOI: 10.2217/pgs-2021-0125.
Development and Implementation of In-House Pharmacogenomic Testing Program at a Major Academic Health System.
Mroz P, Michel S, Allen J, Meyer T, McGonagle E, Carpentier R
Front Genet. 2021; 12:712602.
PMID: 34745204
PMC: 8564018.
DOI: 10.3389/fgene.2021.712602.
Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
Duarte J, Dalton R, Elchynski A, Smith D, Cicali E, Lee J
Genet Med. 2021; 23(12):2335-2341.
PMID: 34282303
PMC: 8633054.
DOI: 10.1038/s41436-021-01269-9.
Moving Pharmacogenetics Into Practice: It's All About the Evidence!.
Luzum J, Petry N, Taylor A, Van Driest S, Dunnenberger H, Cavallari L
Clin Pharmacol Ther. 2021; 110(3):649-661.
PMID: 34101169
PMC: 8376790.
DOI: 10.1002/cpt.2327.
Pharmacogenetics to guide cardiovascular drug therapy.
Duarte J, Cavallari L
Nat Rev Cardiol. 2021; 18(9):649-665.
PMID: 33953382
PMC: 8364496.
DOI: 10.1038/s41569-021-00549-w.
Opportunity for Genotype-Guided Prescribing Among Adult Patients in 11 US Health Systems.
Hicks J, El Rouby N, Ong H, Schildcrout J, Ramsey L, Shi Y
Clin Pharmacol Ther. 2021; 110(1):179-188.
PMID: 33428770
PMC: 8217370.
DOI: 10.1002/cpt.2161.
Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
Ramsey L, Ong H, Schildcrout J, Shi Y, Tang L, Hicks J
JAMA Netw Open. 2020; 3(12):e2029411.
PMID: 33315113
PMC: 7737091.
DOI: 10.1001/jamanetworkopen.2020.29411.
